• Sonuç bulunamadı

New Impact Factor and the New Issue

N/A
N/A
Protected

Academic year: 2021

Share "New Impact Factor and the New Issue"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Editorial

New Impact Factor and the New Issue

69

During the past month, we learned that the impact factor of our journal has risen to 1,271, which has made us very happy and proud. Although this rate of increase may appear to be low, continuity and consistency is also of great importance. This success has been achieved thanks to the efforts of our former editors and our authors and we would like to express our thanks to them. Our journal is already demonstrating remarkable success in the national and international arena, but be that as it may, we all have responsibilities to improve it even further.

New manuscripts in this issue include:

ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) is a relatively new scoring sys-tem for predicting long-term prognosis in patients with acute myocardial infarction compared with other systems, especially the GRACE (Global Registry of Acute Coronary Events) risk score. Gökhan Çetinkal et al. have found that the ATRIA risk score is more user-friendly and has the added value of predicting long-term adverse events in a group of patients other than those with atrial fibrillation.

Wei Meng et al., from China, have analyzed the degree of inflammation present and the effects on the biomechanical strength of the involved aorta in Type A aortic dissection and ascending thoracic aortic aneurysm.

E. Bilal Karaayvaz et al., from Turkey, have evaluated ventricular repolarization parameters in patients with Turner syndrome, and the findings provide some pointers that can help prevent sud-den death in these patients.

Xueiun Jiang et al., also from China, have studied coronary heart disease (CHD) in patients with heart failure (HF) and CHD patients without HF according to peripheral blood mononuclear cell miRNA profiles. They found that a combination of some miRNAs, as well as hypertension, correlate with an increased risk of HF in CHD patients, and that this could be a biomarker.

For patients with acute HF, a higher diuretic dose during the first 72 hours predicts a longer stay in the hospital. This conclusion comes from Hirotaka Kato et al., from the USA.

In their article, Manolis Vavuranakis et al., from Greece, have examined computational imaging of the aortic vasa vasorum and neovascularization in rabbits using contrast-enhanced intravascu-lar ultrasound (CE-IVUS) and conducted a histological analysis. Histology confirmed the CE-IVUS images. These findings could be extrapolated to clinical determinations of vulnerable plaque.

I hope this new issue of AJC will be a rich source of interest to our readers. Prof. Dr. Çetin Erol

Editor-in-Chief Ankara, Turkey

©Copyright 2018 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com DOI:10.14744/AnatolJCardiol.2018.8

Address for Correspondence: Prof. Dr. Çetin Erol, Ankara Üniversitesi Tıp Fakültesi, İbn-i Sina Hastanesi, Kardiyoloji Anabilim Dalı, Ankara-Türkiye

Referanslar

Benzer Belgeler

(Turkey) have aimed to evaluate the accuracy of original and simplified PESI to predict all-cause mortality after 30 days of acute PE diagnosis up to five years within

Similarly, the DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT) study (39) compared the OMI/NOMI approach with

from Pakistan aimed to compare the safety profile of the PreludeSYNC DISTAL radial compression device (PSD; Merit Medical Systems, Inc., South Jordan, UT, USA) and the TR band

The shunt angle should not be directed toward the narrow pulmonary artery (right or left) since total pulmo- nary flow rates decrease.. Furthermore, vertical anastomosis

Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events

An analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibitor Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial

CI - confidence interval; DPR - dual poor responsiveness; HTPR - high on-treatment platelet reactivity; NYHA - New York Heart Association; PRA - poor responsiveness to aspirin; PRC

The objective of the present study is to figure out the relation between admission sK level and in-hospi- tal mortality, ventricular arrhythmias, long-term (six months) mortality,